By Joshua Kappel, Barine Majewska
Aug 23, 2024
Colorado’s Department of Regulatory Agencies and Department of Revenue have finalized rules for facilitator licensing and business operations under the Natural Medicine program, which launches January 1. Read on for the latest update on the rules, local government restrictions and proposed licensing and application fees.
By Vicente LLP, Psychedelic Alpha
Aug 21, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. As the first round of rulemaking for Colorado’s regulated Natural Medicine program comes to a close, Vicente LLP and Psychedelic Alpha provide an overview of the first set of final rules which give a good picture of how the state will regulate facilitators, their training programs, and other Natural Medicine Businesses.
By Vicente LLP, Psychedelic Alpha
Aug 21, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. The Natural Medicine Advisory Board (“NMAB”), as well as the Federally Recognized Tribes and Indigenous Community Working Group, are continuing to develop recommendations. The Department of Revenue (“DOR”) has concluded its initial rulemaking, having released a final set of consolidated draft rules and held final public comment.
By Shawn Hauser
Aug 1, 2024
Last Monday marked the end of the historic DEA public comment period for marijuana’s proposed rescheduling to Schedule III. What happens now and how might election dynamics have an impact?
By Jason Adelstone
Jul 24, 2024
Despite growing public support, EU nations face significant legal hurdles in establishing commercial marijuana markets due to international drug treaties and EU regulations. This Insights post highlights the various approaches toward cannabis reform taken by countries like Germany, Malta, the Netherlands, Switzerland, and the Czech Republic, and how this could potentially impact future cannabis policies in Europe.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.